Literature DB >> 22523381

Muscle cyclo-oxygenase-2 pathway contributes to the exaggerated muscle mechanoreflex in rats with congestive heart failure.

Ariel Morales1, Wei Gao, Jian Lu, Jihong Xing, Jianhua Li.   

Abstract

Cyclo-oxygenase (COX) enzymes are responsible for the formation from arachidonic acid of prostaglandins, among other metabolites. Prior studies have suggested that inhibition of the COX pathway attenuates the responses of sympathetic nerve activity and blood pressure during static muscle contraction. Static muscle contraction activates the exercise pressor reflex, which in turn increases sympathetic nerve activity and blood pressure. Also, COX products contribute to exaggeration of the exercise pressor reflex in heart failure (HF). This dysfunction of the exercise pressor reflex has previously been shown to be mediated primarily by muscle mechanoreflex overactivity. It is well known that COX-1 and COX-2 are two isoforms of the enzyme that lead to formation of these important biological mediators involved in the muscle reflex. Thus, in the present study, we determined whether the COX-1 and/or COX-2 pathway contribute(s) to the augmented mechanoreflex activity in HF. First, Western blot analysis was employed to examine protein expression of COX-1 and COX-2 in skeletal muscle tissue of control rats and rats with HF induced by myocardial infarction. Our data show that there is no significant difference in COX-1 expression in both experimental groups. However, COX-2 displays significant overexpression in rats with HF compared with control rats (optical density 1.06 ± 0.05 in control and 1.6 ± 0.05 in HF, P < 0.05 versus control). Second, the mechanoreflex was evoked by passive tendon stretch, and the reflex sympathetic and pressor responses to muscle stretch were examined after COX-1 and COX-2 inhibitors (FR-122047 and SC-236) were individually injected into the arterial blood supply of the hindlimb muscles. The results demonstrate that the stretch-evoked reflex responses in rats with HF were significantly attenuated by administration of SC-236, but not by FR-122047, i.e. renal sympathetic nerve activity and mean arterial pressure responses evoked by 0.5 kg of muscle tension were 52.3 ± 8.9% and 19 ± 1.4 mmHg, respectively, in control conditions and 26.4 ± 5.6% and 5.7 ± 1.6 mmHg (P < 0.05 versus control group) after 0.25 mg kg(-1) of SC-236. Muscle stretch-evoked renal sympathetic nerve activity and mean arterial pressure responses were 51.8 ± 8.2% and 18.7 ± 1.2 mmHg, respectively, in control conditions and 48.3 ± 5.3% and 17.5 ± 1.9 mmHg (P > 0.05 versus control group) after 1.0 mg kg(-1) of FR-122047. Accordingly, the results obtained from this study support our hypothesis that heightened COX-2 expression within the hindlimb muscles contributes to the exaggerated muscle mechanoreflex in congestive HF.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22523381      PMCID: PMC3606264          DOI: 10.1113/expphysiol.2012.065425

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  45 in total

1.  ATP stimulates chemically sensitive and sensitizes mechanically sensitive afferents.

Authors:  Jianhua Li; Lawrence I Sinoway
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-12       Impact factor: 4.733

2.  Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation.

Authors:  J N Francischi; C T Chaves; A C L Moura; A S Lima; O A Rocha; D L Ferreira-Alves; Y S Bakhle
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

3.  Reflex cardiovascular and respiratory responses originating in exercising muscle.

Authors:  D I McCloskey; J H Mitchell
Journal:  J Physiol       Date:  1972-07       Impact factor: 5.182

Review 4.  The exercise pressor reflex: its cardiovascular effects, afferent mechanisms, and central pathways.

Authors:  J H Mitchell; M P Kaufman; G A Iwamoto
Journal:  Annu Rev Physiol       Date:  1983       Impact factor: 19.318

Review 5.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312

6.  Prostaglandin synthesis blockade by ketoprofen attenuates respiratory and cardiovascular responses to static handgrip.

Authors:  G A Fontana; T Pantaleo; F Bongianni; F Cresci; F Lavorini; C T Guerra; P Panuccio
Journal:  J Appl Physiol (1985)       Date:  1995-02

7.  Cardiovascular and respiratory responses to changes in central command during isometric exercise at constant muscle tension.

Authors:  G M Goodwin; D I McCloskey; J H Mitchell
Journal:  J Physiol       Date:  1972-10       Impact factor: 5.182

8.  Putative contribution of prostaglandin and bradykinin to muscle reflex hyperactivity in patients on Ace-inhibitor therapy for chronic heart failure.

Authors:  Adam C Scott; Roland Wensel; Constantinos H Davos; Panagiota Georgiadou; L Ceri Davies; Andrew J S Coats; Darrel P Francis; Massimo F Piepoli
Journal:  Eur Heart J       Date:  2004-10       Impact factor: 29.983

9.  Cyclooxygenase products sensitize muscle mechanoreceptors in healthy humans.

Authors:  Holly R Middlekauff; Josephine Chiu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-11       Impact factor: 4.733

10.  Differential antinociceptive effects induced by a selective cyclooxygenase-2 inhibitor (SC-236) on dorsal horn neurons and spinal withdrawal reflexes in anesthetized spinal rats.

Authors:  H J You; C D Mørch; J Chen; L Arendt-Nielsen
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

View more
  13 in total

1.  Influence of the metaboreflex on arterial blood pressure in heart failure patients.

Authors:  Manda L Keller-Ross; Bruce D Johnson; Michael J Joyner; Thomas P Olson
Journal:  Am Heart J       Date:  2014-01-06       Impact factor: 4.749

2.  Investigation of the mechanisms of cyclooxygenase-mediated mechanoreflex sensitization in a rat model of simulated peripheral artery disease.

Authors:  Alec L E Butenas; Tyler D Hopkins; Korynne S Rollins; Kennedy P Felice; Steven W Copp
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-08-30       Impact factor: 4.733

3.  ASIC3 contributes to the blunted muscle metaboreflex in heart failure.

Authors:  Jihong Xing; Jian Lu; Jianhua Li
Journal:  Med Sci Sports Exerc       Date:  2015-02       Impact factor: 5.411

4.  Metabo- and mechanoreceptor expression in human heart failure: Relationships with the locomotor muscle afferent influence on exercise responses.

Authors:  Joshua R Smith; Corey R Hart; Paola A Ramos; Joshua G Akinsanya; Ian R Lanza; Michael J Joyner; Timothy B Curry; Thomas P Olson
Journal:  Exp Physiol       Date:  2020-03-29       Impact factor: 2.969

5.  Muscle mechanoreflex activation via passive calf stretch causes renal vasoconstriction in healthy humans.

Authors:  Rachel C Drew; Cheryl A Blaha; Michael D Herr; Ruda Cui; Lawrence I Sinoway
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-04-05       Impact factor: 3.619

6.  Cyclooxygenase inhibition does not impact the pressor response during static or dynamic mechanoreflex activation in healthy decerebrate rats.

Authors:  Korynne S Rollins; Tyler D Hopkins; Alec L Butenas; Kennedy P Felice; Carl J Ade; Steven W Copp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-06-26       Impact factor: 3.619

7.  Thromboxane A2 receptors mediate chronic mechanoreflex sensitization in a rat model of simulated peripheral artery disease.

Authors:  Korynne S Rollins; Alec L E Butenas; Kennedy P Felice; Jacob E Matney; Auni C Williams; Talyn E Kleweno; Steven W Copp
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-12       Impact factor: 4.733

8.  Molecular basis for the improvement in muscle metaboreflex and mechanoreflex control in exercise-trained humans with chronic heart failure.

Authors:  Ligia M Antunes-Correa; Thais S Nobre; Raphaela V Groehs; Maria Janieire N N Alves; Tiago Fernandes; Gisele K Couto; Maria Urbana P B Rondon; Patricia Oliveira; Marta Lima; Wilson Mathias; Patricia C Brum; Charles Mady; Dirceu R Almeida; Luciana V Rossoni; Edilamar M Oliveira; Holly R Middlekauff; Carlos E Negrao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-10-10       Impact factor: 4.733

9.  No effect of endoperoxide 4 or thromboxane A2 receptor blockade on static mechanoreflex activation in rats with heart failure.

Authors:  Alec L E Butenas; Korynne S Rollins; Jacob E Matney; Auni C Williams; Talyn E Kleweno; Shannon K Parr; Stephen T Hammond; Carl J Ade; Karen S Hageman; Timothy I Musch; Steven W Copp
Journal:  Exp Physiol       Date:  2020-10-06       Impact factor: 2.969

10.  Exaggerated sympathetic and cardiovascular responses to dynamic mechanoreflex activation in rats with heart failure: Role of endoperoxide 4 and thromboxane A2 receptors.

Authors:  Alec L E Butenas; Korynne S Rollins; Auni C Williams; Shannon K Parr; Stephen T Hammond; Carl J Ade; K Sue Hageman; Timothy I Musch; Steven W Copp
Journal:  Auton Neurosci       Date:  2021-02-13       Impact factor: 3.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.